Trial intelligence / Profile preview

Effect of magnesium sulfate on epilepsy and cesarean section in mild preeclampsia

IRCT2016052111020N5Phase 3Completed

Sponsor
Vice chancellor of Zahedan University of Medical Sciences
Start
Nov 2016
Modality
Small Molecules
Countries
1
01

Overview

Phase 3 trial of magnesium sulfate in preeclampsia, sponsored by Vice chancellor of Zahedan University of Medical Sciences. Primary endpoints: Incidence of eclampsia and Rate of cesarean section. Started Nov 2016; status: completed.

02

Drugs

magnesium sulfate
03

Conditions

preeclampsia

Beyond the preview

Go deeper on IRCT2016052111020N5.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT2016052111020N5.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call